Oncobiologics, Inc. 4
4 · Oncobiologics, Inc. · Filed May 17, 2016
Insider Transaction Report
Form 4
Bahrt Kenneth
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-05-13+2,000→ 2,000 total - Purchase
Series A Warrants (right to buy)
2016-05-13+1,000→ 1,000 totalExercise: $6.60Exp: 2017-02-18→ Common Stock (1,000 underlying) - Purchase
Series B Warrants (right to buy)
2016-05-13+1,000→ 1,000 totalExercise: $8.50Exp: 2018-05-18→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]The reported securities are included within 2,000 Units purchased by the reporting person for $6.00 per Unit. Each Unit consists of one share of common stock, one half of a Series A warrant to purchase one share of common stock and one half of a Series B Warrant to purchase one share of common stock
- [F2]The Series A Warrants and Series B Warrants will be exercisable 30 days after 5/12/16 or on such date the underwriters separate the units, whichever date is earlier.